The impact of continuing medical education on opioid prescribing practices
Journal of Opioid Management · 2026
DOI: 10.5055/jom.0997 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Opioid Management, 2026. Verfasst von Melissa B Weimer und 3 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine; Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut. ORCID: https://orcid.org/0000-0002-5624-…. Hauptthemen laut MEDLINE: Analgesics, Opioid, Education, Medical, Continuing, Practice Patterns, Physicians'. Die Arbeit nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objective
Clinician adherence to clinical guidelines after engaging in continuing medical education (CME) is often limited to self-report. We sought to determine the impact of a CME course addressing safer opioid prescribing on clinician opioid-related prescribing practices for patients prescribed opioids for pain.
Design
A retrospective cohort study.
Setting
Single health system, Northeast United States.Subjects: Clinician prescribers of opioids (Medical Doctor/Doctor of Osteopathy, Doctor of Podiatric Medicine, Nurse Practitioner, Physician Assistant) who did and did not complete a CME program.
Methods
Practice adherence to the Food and Drug Administration Opioid Analgesia Risk Evaluation and Management Strategies (REMS) Education Blueprint was assessed by comparing electronic health record data from clinicians who participated in a CME course (REMS-OA+) with data from matched clinicians who did not (REMS-OA–). We compared prescribing practices, including opioid dose and patient-level outcomes, including visit type, naloxone prescription, and urine drug testing, before and after CME participation. A difference-in-differences (DiD) approach estimated the absolute change in prescribing practices and patient-level outcomes.
Results
A total of 49 clinicians completed a portion of the REMS-OA CME and prescribed opioids during the study period. After adjustment, the absolute DiD for prescribing practices and patient-level outcomes was not significantly different between REMS-OA+ prescribers and REMS-OA– prescribers. The only significant difference was that REMS-OA+ prescribers completed more in-person visits compared with telemedicine visits than REMS-OA– prescribers.
Conclusions
We did not detect significant differences in clinician adherence to clinical guidance between the REMS-OA CME groups. Improved adherence to guidelines for opioid prescribing likely requires both CME and additional interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Yale School of Medicine; Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut. ORCID: https://orcid.org/0000-0002-5624-2434.
- Center for Analytical Sciences, Yale School of Public Health, New Haven, Connecticut.
- Yale School of Medicine; Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut. ORCID: https://orcid.org/0000-0002-4006-010X.
- The George Washington University, Washington, DC.
Zitieren
APA
Weimer, M. B., Wang, K., Fiellin, D. A., & Warner, M. L. (2026). The impact of continuing medical education on opioid prescribing practices. Journal of Opioid Management. https://doi.org/10.5055/jom.0997
Vancouver
Weimer MB, Wang K, Fiellin DA, Warner ML. The impact of continuing medical education on opioid prescribing practices. Journal of Opioid Management. 2026. doi:10.5055/jom.0997
BibTeX
@article{Weimer2026,
author = {Weimer, Melissa B and Wang, Kaicheng and Fiellin, David A and Warner, Mary L},
title = {The impact of continuing medical education on opioid prescribing practices},
journal = {Journal of Opioid Management},
year = {2026},
doi = {10.5055/jom.0997}
}
EUVIMED